Literature DB >> 7310430

Myotonic dystrophy and thymoma.

L Carlin, J Biller.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7310430      PMCID： PMC491151          DOI： 10.1136/jnnp.44.9.852-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

Review 1.  The spectrum of diseases associated with thymoma. Coincidence or syndrome?

Authors:  J V Souadjian; P Enriquez; M N Silverstein; J M Pépin
Journal:  Arch Intern Med       Date:  1974-08

2.  Myotonic dystrophy and thymoma: a necropsy case report.

Authors:  Y Kuroiwa; A Yamada; K Ikebe; K Kosaka; H Sugita; T Murakami
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

3.  Immunologic derangement in myotonic dystrophy--abnormal contact sensitization to dinitrochlorobenzene.

Authors:  Y Kuroiwa; H Sugita; Y Toyokura; M Mizoguchi; H Matsuo; Y Nonaka
Journal:  J Neurol Sci       Date:  1980-08       Impact factor: 3.181
  3 in total
  4 in total

1.  Imaging of the thymus in myotonic dystrophy type 1.

Authors:  Andrea Mignarri; Francesco Gentili; Francesco Masia; Angelo Genua; Silvia Cenciarelli; Paola Brunori; Maria Antonietta Mazzei; Alessandro Malandrini; Antonio Federico; Francesco Giuseppe Mazzei; Maria Teresa Dotti
Journal:  Neurol Sci       Date:  2017-11-25       Impact factor: 3.307

2.  Increased cancer risks in myotonic dystrophy.

Authors:  Aung Ko Win; Promilla G Perattur; Jose S Pulido; Christine M Pulido; Noralane M Lindor
Journal:  Mayo Clin Proc       Date:  2012-01-10       Impact factor: 7.616

Review 3.  Multiple thymoma with myotonic dystrophy.

Authors:  T Hirai; A Yamanaka; T Fujimoto; A Takahashi; Y Takayama; K Yamanaka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-07

Review 4.  Hypothesis: neoplasms in myotonic dystrophy.

Authors:  Christine M Mueller; James E Hilbert; William Martens; Charles A Thornton; Richard T Moxley; Mark H Greene
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.